Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8765700 | Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions | George Tachas, James Karras, Jeffrey R. Crosby, Kenneth Dobie, Frank Bennett | 2014-07-01 |
| 8153603 | Compositions and their uses directed to IL-4R alpha | James Karras, Jeffrey R. Crosby, Mausumee Guha, David Tung, Susan M. Freier | 2012-04-10 |
| 7507810 | Compositions and their uses directed to IL-4R alpha | James Karras, Susan M. Freier, William Gaarde, Mausumee Guha | 2009-03-24 |
| 7141599 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin | Peter Isakson, Gary Anderson | 2006-11-28 |
| 7132441 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | Peter C. Isakson, Gary Anderson | 2006-11-07 |
| 6617345 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin | Peter C. Isakson, Gary Anderson | 2003-09-09 |
| 6407140 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor | Peter C. Isakson, Gary Anderson | 2002-06-18 |
| 6376528 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | Peter C. Isakson, Gary Anderson | 2002-04-23 |
| 6342510 | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitors and a leukotriene B4 receptor antagonist | Peter C. Isakson, Gary Anderson | 2002-01-29 |
| 6265439 | Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives | Richard A. Mueller, Thomas E. Barta, John McKearn, Richard A. Partis, Francis J. Koszyk | 2001-07-24 |
| 6172096 | Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist | Peter C. Isakson, Gary Anderson | 2001-01-09 |
| 6136839 | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor | Peter C. Isakson, Gary Anderson | 2000-10-24 |
| 5990148 | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A.sub.4 hydrolase inhibitor | Peter C. Isakson, Gary Anderson | 1999-11-23 |
| 5700816 | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A.sub.4 hydrolase inhibitor | Peter C. Isakson, Gary Anderson | 1997-12-23 |
| 5451604 | Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives | Richard A. Mueller, Thomas E. Barta, John McKearn, Richard A. Partis, Francis J. Koszyk | 1995-09-19 |
| 5247119 | Phenylacetonitrilehydroxyalkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives | Kerry W. Fowler, John Farah, John McKearn, Richard A. Mueller | 1993-09-21 |
| 4785077 | Substantially pure cytotoxicity triggering factor | Richard Syd Kornbluth, Thomas S. Edgington | 1988-11-15 |